ThermoFisher will buy Affymetrix to expand genetic testing


Laboratory supplies megalith ThermoFisher Scientific has agreed to buy US life science technology developer Affymetrix for around $1.3 billion (£900 million).

The deal will bring Thermo’s massive global sales and distribution network to bear on Affymetrix’s products, and boost Thermo’s position in the fast-growing areas of genetic testing, antibodies and assay technology.

Affymetrix develops genetic testing products directed at research and applied markets. A partnership with UK firm Bio-Genesys supplies genotyping services for farm animals to support selective breeding programmes.


Related Content

US opens up home DNA screening

25 February 2015 Business

news image

FDA approves single disease genetic test and clears pathway for similar devices

Faster, cheaper, better

24 September 2014 Premium contentFeature

news image

Microfluidics researchers are aiming to bring new diagnostic devices into mainstream medicine. Mark Peplow reports

Most Commented

Crawling chemical system acts as if it’s alive

24 May 2016 Research

news image

Intriguing globule that moves, eats and defecates

Let's see that again

27 May 2016 In the Pipeline

news image

Has chemistry evaded the reproducibility crises affecting other branches of science? Or is it just a question of scale, asks ...